The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:
- Home
- Events
- Antibody-Drug Conjugates,...
- Event Overview
Registration
Download Brochure
Add to Outlook Calendar
Related Events
-
August 06-08, 2012 -
August 06-08, 2012 -
August 06-08, 2012 -
August 06-08, 2012
Find Another IBC Event
Antibody-Drug Conjugates, Bispecifics & Empowered Antibodies
CSS
Toolbar
Event Overview
Are you looking to design BETTER next-generation ADCs, bispecifics and empowered molecules?
How do you decide which antibody platform is best for your specific disease biology?
Transforming Clinical and Disease Biology Insights into Drug & Diagnostic Discoveries
Your registration includes FREE Access to these 3 co-located summits:
Next-Gen Sequencing Applications & Translational Technologies
- Rx/Dx Development, Commercialization & Collaboration Models
- Future Clinical Diagnostics
Clinical Biomarkers & New Frontiers in Cancer
View the Event-at-a-Glance (PDF) for all 4 co-located Summits.
Sessions Will Cover
- Novel ADC payloads
- Linker and targeting strategies
- Companion diagnostics for ADCs
- ADCs in the clinic: Learnings to date
- Novel bispecific MOA
- Empowering the immune system
- Manufacturability considerations
- Expanding "druggable" target space
ADC Thought-Leaders Discussion and Debate
Tuesday, August 7, 5:00 pm
Strategies to Design and Optimize Properties of Next-Generation of ADCs
Scientific and Strategic Insights
from Thought-Leading Speakers:
Jonathan Drachman |
Jon Terret |
Sara Hurvitz |
Hans-Peter Gerber |
Plus many more...
View the Entire Line-up of Keynote & Featured Speakers
Interactive Panel Discussion
...to help you design better molecules
Wednesday, August 8, 4:15 pm
Which Antibody Platform is Best Suited to Your Specific Disease Biology?
What You Will Gain by Attending:
- Hear strategies for designing better next-generation ADCs and optimizing ADC properties.
- Learn about novel bispecific mechanisms of action, antibody mixtures and how to gain a competitive edge for your molecule.
- Bispecific vs, Mixture vs, Monospecific - when do two mono-specific antibodies used in combination have a biological/ clinical advantage over a bispecific?
Copyright IBC Life Sciences, a part of Informa Life Sciences Group. Phone: 800.390.4078 Email: reg@ibcusa.com